Aadi Bioscience Stock Investor Sentiment
| AADI Stock | USD 2.05 0.05 2.38% |
Under 67% of Aadi Bioscience's investor base is looking to short. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that many traders are alarmed. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
Aadi |
Aadi Bioscience Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Far too much social signal, news, headlines, and media speculation about Aadi Bioscience that are available to investors today. That information is available publicly through Aadi media outlets and privately through word of mouth or via Aadi internal channels. However, regardless of the origin, that massive amount of Aadi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aadi Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aadi Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aadi Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aadi Bioscience alpha.
Aadi Bioscience Performance against Dow Jones
Price Growth (%) |
| Timeline |
1 | Insider Trading | 12/19/2024 |
2 | Acquisition by Reeve Emma of 28255 shares of Aadi Bioscience at 8.2 subject to Rule 16b-3 | 12/20/2024 |
3 | Aadi Bioscience, Inc. Shares Sold by Jane Street Group LLC - MarketBeat | 01/16/2025 |
4 | Aadi Bioscience Filed Definitive Proxy Statement and Schedules Special Meeting of Stockholders for February 28, 2025 | 02/05/2025 |
5 | All You Need to Know About Aadi Bioscience Rating Upgrade to Buy | 02/26/2025 |
6 | Acquisition by David Lennon of 16250 shares of Aadi Bioscience subject to Rule 16b-3 | 02/28/2025 |
7 | Disposition of 5690 shares by David Lennon of Aadi Bioscience at 2.35 subject to Rule 16b-3 | 03/03/2025 |
8 | Aadi Bioscience Announces Closing of 100 Million PIPE Financing | 03/04/2025 |
9 | Aadi Bioscience, Inc. Expected to Beat Earnings Estimates Should You Buy | 03/05/2025 |
10 | Acquisition by Giacobello Scott M. of 138263 shares of Aadi Bioscience at 1.92 subject to Rule 16b-3 | 03/10/2025 |
11 | Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update | 03/14/2025 |
Complementary Tools for Aadi Stock analysis
When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |